Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v2.4.0.6
Consolidated Statements of Operations (USD $)
12 Months Ended
Nov. 30, 2011
Nov. 30, 2010
Nov. 30, 2009
Revenues      
Sales of health and beauty aid products, net $ 49,033,367 $ 50,345,213 $ 57,001,999
Other income 478,522 466,429 670,165
Total Revenues 49,511,889 50,811,642 57,672,164
Costs and Expenses      
Cost of sales 20,450,468 21,808,009 21,850,575
Selling, general and administrative expenses 21,967,327 21,139,743 20,037,352
Advertising, cooperative and promotions 5,436,565 7,493,282 9,667,446
Research and development 714,565 619,147 499,636
(Recovery of) doubtful accounts (11,135) (130,192) (4,901)
Interest expense 860 4,033 11,932
Total 48,558,650 50,934,022 52,062,040
Advertising Litigation Expense   2,235,465  
Total Costs and Expenses 48,558,650 53,169,487 52,062,040
Income (Loss) before Provision for (Benefit from) Income Taxes 953,239 (2,357,845) 5,610,124
Provision for (Benefit from) income taxes 461,541 (693,085) 2,178,480
Net Income (Loss) $ 491,698 $ (1,664,760) $ 3,431,644
Weighted Average Shares Outstanding      
Basic 7,054,442 7,054,442 7,054,442
Diluted 7,054,442 7,054,442 7,054,442
Earnings (Loss) Per Common Share (Note 2):      
Basic $ 0.07 $ (0.24) $ 0.49
Diluted $ 0.07 $ (0.24) $ 0.49